Kolmar Korea plans to build its second U.S. plant early next year. To this end, the cosmetics manufacturer has appointed a new head for its North American operations and a Global Chief Commercial Officer (GCCO). It has also set up a strategic framework that integrates production, sales, and R&D to better penetrate the local market. This plan includes creating an R&D team for North America and appointing a new manager.
The company thus appointed: Yongchul Hur as CEO of Kolmar Laboratories and Kolmar USA, its North American subsidiaries; Philippe Warnery as Global Chief Commercial Officer (GCCO); George Rivera as Chief Science Officer (CSO) of the North American subsidiary; and Inki Park as head of the R&D Center for North America, responsible for bridging the Korean and North American markets.
With these recent appointments, Kolmar is adding personalities with considerable experience in the global cosmetics market. The company aims to leverage this strategic hires to maximize the operational capacity of its North American production facilities, including the first U.S. plant and the second plant under construction. The company aims to achieve $100 million in sales in the next five years. To this end, it plans to aggressively expand its sales network not only in North America but also in Central and South America.
Moreover, with the rising popularity of K-beauty in the U.S., Kolmar Korea plans to actively promote ODM sales that emphasize market accessibility and logistics efficiency for small and medium-sized Korean indie brands seeking entry into the U.S. market.
Kolmar Korea has acquired Kolmar USA (formerly known as PTP) and Kolmar Canada (formerly known as CSR) in 2016. In 2022, the company acquired 100% of the ‘Kolmar’ brand trademark rights, securing exclusive rights to the brand and enabling unrestricted business operations in the U.S. and global markets. The company is also expanding its sales network with the recent opening of the Kolmar Innovation Center in New Jersey, USA.
